AAAAAA

   
Results: 1-7 |
Results: 7
QUALITY-OF-LIFE IN PATIENTS ON CHRONIC DIALYSIS - SELF-ASSESSMENT 3 MONTHS AFTER THE START OF TREATMENT
Authors: MERKUS MP JAGER KJ DEKKER FW BOESCHOTEN EW STEVENS P KREDIET RT BOEKHOUT M BARENDREGT J BULLER HR DECHARRO FT VANES A VANGEELEN JACA GEERLINGS W GERLAG PGG GORGELS JPMC HUISMAN RM KONINGMULDER WAH KOOLEN MI LEUNISSEN KML VANLEUSEN R PARLEVLIET KJ SCHRODER CH TIJSSEN JGP VALENTIJN RM VINCENT HH VOS P
Citation: Mp. Merkus et al., QUALITY-OF-LIFE IN PATIENTS ON CHRONIC DIALYSIS - SELF-ASSESSMENT 3 MONTHS AFTER THE START OF TREATMENT, American journal of kidney diseases, 29(4), 1997, pp. 584-592
TOXICITY OF OKT3 INCREASES WITH DOSAGE - A CONTROLLED-STUDY IN RENAL-TRANSPLANT RECIPIENTS
Authors: PARLEVLIET KJ BEMELMAN FJ YONG SL HACK CE SURACHNO J WILMINK JM TENBERGE IJM SCHELLEKENS PTA
Citation: Kj. Parlevliet et al., TOXICITY OF OKT3 INCREASES WITH DOSAGE - A CONTROLLED-STUDY IN RENAL-TRANSPLANT RECIPIENTS, Transplant international, 8(2), 1995, pp. 141-146
EFFECTS OF ANTI-CD3 MONOCLONAL-ANTIBODIES ON FUNCTIONAL-ACTIVITY OF LYMPHOCYTES - STUDIES IN-VIVO AND IN-VITRO
Authors: PARLEVLIET KJ CHAMULEAU MED YONG SL RAASVELD MHM TENBERGE IJM SCHELLEKENS PTA
Citation: Kj. Parlevliet et al., EFFECTS OF ANTI-CD3 MONOCLONAL-ANTIBODIES ON FUNCTIONAL-ACTIVITY OF LYMPHOCYTES - STUDIES IN-VIVO AND IN-VITRO, Clinical and experimental immunology, 99(2), 1995, pp. 155-159
LOW-DOSE OKT3 INDUCTION THERAPY FOLLOWING RENAL-TRANSPLANTATION - A CONTROLLED-STUDY
Authors: PARLEVLIET KJ TENBERGE RJM RAASVELD MHM SURACHNO J WILMINK JM SCHELLEKENS PTA
Citation: Kj. Parlevliet et al., LOW-DOSE OKT3 INDUCTION THERAPY FOLLOWING RENAL-TRANSPLANTATION - A CONTROLLED-STUDY, Nephrology, dialysis, transplantation, 9(6), 1994, pp. 698-703
TOXICITY OF IGA ANTI-CD3 ISOTYPE SWITCH VARIANT IN-VIVO
Authors: TENBERGE IJM PARLEVLIET KJ YONG SL SURACHNO J WILMINK JM SCHELLEKENS PTA
Citation: Ijm. Tenberge et al., TOXICITY OF IGA ANTI-CD3 ISOTYPE SWITCH VARIANT IN-VIVO, Transplantation proceedings, 26(6), 1994, pp. 3150-3150
IN-VIVO EFFECTS OF IGA AND IGG2A ANTI-CD3 ISOTYPE SWITCH VARIANTS
Authors: PARLEVLIET KJ TENBERGE IJM YONG SL SURACHNO J WILMINK JM SCHELLEKENS PTA
Citation: Kj. Parlevliet et al., IN-VIVO EFFECTS OF IGA AND IGG2A ANTI-CD3 ISOTYPE SWITCH VARIANTS, The Journal of clinical investigation, 93(6), 1994, pp. 2519-2525
IN-VIVO EFFECTS OF IGA AND IGG2A ANTI-CD3 ISOTYPE SWITCH VARIANTS - ADOUBLE-BLIND-STUDY IN RENAL-TRANSPLANT RECIPIENTS
Authors: PARLEVLIET KJ",INEKE,"TENBERGE JM YONG SL SURACHNO J WILMINK JM SCHELLEKENS PTA
Citation: Jm. Parlevliet Kj",ineke,"tenberge et al., IN-VIVO EFFECTS OF IGA AND IGG2A ANTI-CD3 ISOTYPE SWITCH VARIANTS - ADOUBLE-BLIND-STUDY IN RENAL-TRANSPLANT RECIPIENTS, Kidney international, 44(5), 1993, pp. 1198-1198
Risultati: 1-7 |